Acta Neuropathologica Communications (Dec 2020)

Cerebral organoids: emerging ex vivo humanoid models of glioblastoma

  • Michail-Dimitrios Papaioannou,
  • Kevin Sangster,
  • Rifat Shahriar Sajid,
  • Ugljesa Djuric,
  • Phedias Diamandis

DOI
https://doi.org/10.1186/s40478-020-01077-3
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Glioblastoma is an aggressive form of brain cancer that has seen only marginal improvements in its bleak survival outlook of 12–15 months over the last forty years. There is therefore an urgent need for the development of advanced drug screening platforms and systems that can better recapitulate glioblastoma’s infiltrative biology, a process largely responsible for its relentless propensity for recurrence and progression. Recent advances in stem cell biology have allowed the generation of artificial tridimensional brain-like tissue termed cerebral organoids. In addition to their potential to model brain development, these reagents are providing much needed synthetic humanoid scaffolds to model glioblastoma’s infiltrative capacity in a faithful and scalable manner. Here, we highlight and review the early breakthroughs in this growing field and discuss its potential future role for glioblastoma research.

Keywords